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Abstract
Background: Invasive aspergillosis (IA) is a major cause of infectious morbidity and mortality in immune
compromised patients. Studies on the pathogenesis of IA have been limited by the difficulty to monitor disease
progression in real-time. For real-time monitoring of the infection, we recently engineered a bioluminescent
A. fumigatus strain.
Results: In this study, we demonstrate that bioluminescence imaging can track the progression of IA at different
anatomic locations in a murine model of disease that recapitulates the natural route of infection. To define the
temporal and functional requirements of distinct innate immune cellular subsets in host defense against respiratory
A. fumigatus infection, we examined the development and progression of IA using bioluminescence imaging and
histopathologic analysis in mice with four different types of pharmacologic or numeric defects in innate immune
function that target resident and recruited phagocyte subsets. While bioluminescence imaging can track the
progression and location of invasive disease in vivo, signals can be attenuated by severe inflammation and
associated tissue hypoxia. However, especially under non-inflammatory conditions, such as cyclophosphamide
treatment, an increasing bioluminescence signal reflects the increasing biomass of alive fungal cells.
Conclusions: Imaging studies allowed an in vivo correlation between the onset, peak, and kinetics of hyphal tissue
invasion from the lung under conditions of functional or numeric inactivation of phagocytes and sheds light on
the germination speed of conidia under the different immunosuppression regimens. Conditions of high
inflammation -either mediated by neutrophil influx under corticosteroid treatment or by monocytes recruited
during antibody-mediated depletion of neutrophils- were associated with rapid conidial germination and caused
an early rise in bioluminescence post-infection. In contrast, 80% alveolar macrophage depletion failed to trigger a
bioluminescent signal, consistent with the notion that neutrophil recruitment is essential for early host defense,
while alveolar macrophage depletion can be functionally compensated.
Background
Morbidity and mortality caused by invasive Aspergillus
infections are increasing due to an expansion in the
number of patients receiving potent myeloablative and
immunosuppressive regimens for transplantation and
the treatment of malignancy and autoimmune disorders
[1,2]. Patients with hematologic malignancies and
recipients of allogeneic hematopoietic stem cell trans-
plants (HSCT) belong to high-risk groups for invasive
aspergillosis (IA).
IA is the most common invasive mould infection in
immunocompromised patients. Although neutropenia
following the conditioning regimen remains an impor-
tant risk factor for IA in the early post-transplant per-
iod, most cases of IA in allogeneic HSCT recipients
occur after neutrophil recovery in the setting of potent
immunosuppressive therapy for graft-versus-host disease
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transplant period with corticosteroids and potent immu-
nosuppressive therapy contributes to the risk for IA
[3-7].
In immune competent hosts, pulmonary alveolar
macrophages (AM) coordinate the early inflammatory
response and ingest and kill the inhaled conidia [8,9].
Besides ingesting inhaled conidia, AMs are believed to
play a key role in orchestrating the inflammatory
response to A. fumigatus. Pattern recognition receptors
(PRR) on AM recognize specific fungal cell wall motifs
displayed during the conidial and hyphal stages and pro-
duce cytokines and chemokines that stimulate neutro-
phil recruitment and subsequent antigen-specific
immunity. Recent studies have demonstrated the key
role of PRR in regulating innate and antigen-dependent
immunity in response to fungal infections [10,11]. For
instance, b-glucan that is exposed on the surface of
Aspergillus germinating conidia and hyphal cells (but
not resting conidia) is recognized by the C-type lectin,
dectin-1 [12-14].
In addition to AMs, other innate immune cells that
include neutrophils, monocytes and NK T cells have
important antifungal effector roles. The critical role of
neutrophils has been substantiated by the high risk of
IA in patients who have severe and prolonged neutrope-
nia and the lethal course of IA in neutropenic murine
models [15].
Although the past few years have witnessed advances
in our understanding of the pathophysiology of IA, our
understanding of the disease process and the host
response has been hampered by the inability to follow
in vivo fungal growth and dissemination in real time.
We recently generated a bioluminescent A. fumigatus
strain, which constitutively expresses the luciferase from
Photinus pyralis under control of the glyceraldehyde-3-
phosphate dehydrogenase promoter. We showed that
the bioluminescence of this strain correlated well with
fungal biomass under in vitro conditions and demon-
strated that using bioluminescence imaging enables
researchers to monitor the onset of pulmonary IA in
corticosteroid-treated mice [16].
In the present study we applied bioluminescence ima-
ging to an animal model of IA by using different immu-
nosuppression regimens that affect either AM and/or
neutrophil number or function. The primary aim of this
study was to evaluate the suitability of in vivo and ex
vivo bioluminescence imaging to monitor the develop-
ment of invasive aspergillosis. Bioluminescence imaging
was combined with quantitative fungal DNA determina-
tion, histopathologic and morphometric analysis of
infected lung tissues to assess the fungal burden and
progression of IA, the timing and pattern of extrapul-
monary dissemination, and the development of
inflammatory cell infiltrates in the lung. Our results sug-
gest that neutrophils, rather than AM, play an indispen-
sable role in host defense against A. fumigatus.
Results
Pathogenesis of invasive aspergillosis following different
immunosuppression regimens
Different immunosupression regimens were used to
study their impact on murine survival, the development
of invasive aspergillosis (IA), and on fungal growth and
dissemination, using the bioluminescent A. fumigatus
strain C3 [16]. Immune competent mice manifested a
transient weight loss on the day of infection (Figure 1A)
and uniformly survived the infection (Figure 1B). As
expected, mice treated with the alkylating agent cyclo-
phosphamide or the glucocorticoid cortisone acetate
died within five days after infection (Figure 1B) and pro-
gressive infection was accompanied by ongoing weight
loss (Figure 1A). Both treatments are frequently used for
testing the virulence of A. fumigatus and these results
confirmed the virulence of bioluminescent strain C3 in
different infection models.
N e u t r o p h i l sw e r ed e p l e t e db yu s i n gt h em o n o c l o n a l
antibody RB6-8C5, which binds the myeloid differentia-
tion antigen Gr-1 and leads to neutropenia lasting for
three to four days at the dose administered in our
experiments [17]. In agreement with prior studies, tran-
sient neutropenia was sufficient to cause lethal pulmon-
ary aspergillosis (Figure 1B) [17]. However, weight loss
of mice treated with RB6-8C5 was less pronounced than
observed with the other immunosuppressive regimens
(Figure 1A).
We also targeted resident alveolar macrophages by
intranasal instillation of liposomes containing clodronate
(clodrolip). Phagocytosis of clodrolip leads to an intra-
cellular accumulation of clodronate and the induction of
macrophage apoptosis [18]. To confirm that the
observed effects were not due to the instillation with
liposomes, empty liposomes served as a control. The
20% loss of treated mice shown in Figure 1A is due to
the accidental death of one mouse that displayed pul-
monary haemorrhages after drug administration, at
necropsy. After infection, none of the mice treated with
clodrolip showed severe signs of illness and weight loss
was transient (Figure 1A and 1B).
Bioluminescence imaging of infected mice
To understand the specific impact of each immunosup-
pression regimen on fungal growth, we performed in
vivo bioluminescence measurements in different infected
cohorts of mice using A. fumigatus strain C3. Subse-
quently, we performed histopathologic analyses to corre-
late the light emission pattern with fungal invasion and
immune effector cell recruitment.
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Page 2 of 22Figure 1C shows a time response of the quantification
of the luminescence from the thorax of animals treated
with the different immunosuppressive agents. As pre-
viously observed, light emission peaked between day one
and two post-infection in cortisone acetate-treated mice.
A peak in the bioluminescence signal at day two post-
infection was observed in mice that received the RB6-
8C5 antibody. However, the thoracic signal intensity was
much weaker in RB6-8C5-treated mice than in cortisone
acetate-treated mice and hardly exceeded the back-
ground intensity. Despite the low signal intensity,
all mice died four or five days post-infection. Cyclopho-
sphamide treatment, in contrast, induced a more
gradual rise in bioluminescence on day three post-infec-
tion. The signal intensity continued to increase and
remained at a high level until death of the animals at
day five post-infection, implying that biomass formation
may correlate best with bioluminescence development
under this immunosuppresive treatment. Mice treated
with clodrolip did not show overt signs of disease and
the bioluminescence signal remained near the imaging
threshold of approximately 5 × 10
4 -1×1 0
5 total
photon flux per second. This result suggested that
despite AM depletion, no significant hyphal growth
occurred after clodrolip treatment.
In summary, these results suggest that the rapid
increase in bioluminescence, observed in cortisone
acetate-treated mice in particular, but also in RB6-8C5-
treated mice, reflects early conidial germination post-
infection.
Figure 1 Clodrolip treated mice are not susceptible to A. fumigatus intranasal infection.I ne a c he x p e r i m e n t ,g r o u p so f5m i c ew e r e
treated either with cortisone acetate, cyclophosphamide, RB6-8C5 antibody, or clodrolip prior to intranasal infection with 2 × 10
6 conidia of the
luminescent A. fumigatus strain C3. Untreated infected mice are designated as immnocompetent (IC). Weight loss and survival were monitored
for 8 days (A and B). (C): Time response study of luminescence emission from chest region 10 min after intraperitoneal injection of D-luciferin.
Light emission from live animals was recorded for 5 min. Each point represents the average from 3 independent experiments of the total
photon flux measured from a defined thoracic region from each individual animal of the respective cohort (5 mice). (D): Light emission from the
lung of a dead animal immunosuppressed with cortisone acetate following direct injection of D-luciferin. A total photon flux/second of 3.744 ×
10
6 has been measured using the living image software 3.1 after 1 min exposure.
Ibrahim-Granet et al. BMC Microbiology 2010, 10:105
http://www.biomedcentral.com/1471-2180/10/105
Page 3 of 22Correlation of bioluminescence signals with fungal
burden in infected mouse lungs
To correlate our assumption concerning the germina-
tion speed of conidia with the bioluminescence signal
intensities under different immunosuppression regimens,
we performed additional experiments on mice immuno-
suppressed either with cortisone acetate or cyclopho-
sphamide. Mice were infected with the bioluminescent
strain C3 and sacrificed after bioluminescence monitor-
ing on day one or three after infection. Lungs of these
mice were used to determine the fungal burden by
quantification of the fungal DNA among the total DNA
isolated from lung tissues (Figure 2). As observed before
(Figure 1), the development of bioluminescence was
most strongly pronounced at early time points under
cortisone acetate treatment, but declined at later stages
of infection. Contrarily, under cyclophosphamide treat-
ment the bioluminescence signal was hardly detectable
one day after infection, but steadily increased at later
time points (Figure 2, inlet). As assumed, the amount of
Figure 2 Quantitative real-time PCR of fungal DNA enables the correlation between fungal burden and bioluminescence signals. Mice
were immunosuppressed either with cortisone acetate or cyclophosphamide. Two mice from each group were sacrificed at day one and the
other two animals from each group at day three after infection. An uninfected mouse was used as a negative control and revealed no signal in
the qRT-PCR and is, therefore, omitted from the graph. The bars represent the amount of fungal DNA per microgram of total DNA isolated from
the infected tissues with standard deviations from six data points for each individual animal. The two animals investigated for each time point
and immunosuppression regimen show the general tendency that at day one after infection the cortisone acetate treated animals show a
higher burden than the cyclophosphamide treated animals. Three days after infection, the burden with alive fungal cells seems to stay rather
constant under the coticosteroid treatment, but strongly increases under the regimen with cyclophosphamide. The inlet shows the time
response of bioluminescence from alive animals with high values for the cortisone acetate treated mice early after infection followed by a
decline of the signal intensity at later time points. Under cyclophosphamide regimen the bioluminescence steadily increases. The small
photographs above the bars from mice sacrificed at day three show the explanted lungs with an overlay of the emitted light intensities.
Numbers above the photographs give the photons/s × cm
2. The high bioluminescence from lungs explanted from cyclophosphamide treated
animals reflects the higher burden with living fungal cells as determined by the fungal DNA quantification.
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sone acetate treated animals was generally higher than
that of cyclophosphamide treated animals at the same
time point, confirming an increased early germination
rate of conidia under corticosteroid treatment. Surpris-
ingly, the quantity of fungal DNA stayed rather constant
under the corticosteroid regimen. This implies that the
immune response under this treatment either prohibits
further growth of hyphae or even kills fungal cells,
which could explain the decrease in the bioluminescence
signal. However, lungs explanted from mice sacrificed at
day three still showed significant luminescence (Figure
1D and 2). Therefore, we assume that, besides reducing
the expansion of fungal mycelium through the lung tis-
sue, neutrophils cause extensive tissue destruction lead-
ing to tissue hypoxia, which could attenuate the
bioluminescence signal. Oxygen is an essential substrate
for firefly luciferase activity and an oxygen saturation
below 5% significantly decreases light emission [19].
In contrast, treatment with the cytostatic drug cyclo-
phosphamide prevents the recruitment of immune effec-
tor cells to the side of infection. Therefore, despite a
retarded germination of conidia, fungal hyphae stay
alive, which is well visualized by the massive increase in
fungal DNA determined at the late stage of infection
(Figure 2). In agreement, the bioluminescence steadily
increased under this regimen and explanted lungs show
a 50 - 100 times higher light emission than observed
under corticosteroid treatment. This result shows that
bioluminescence measurements and DNA quantification
correlate best under the cyclophophamide regimen.
Although the bioluminescence readout does not corre-
late linearily with the fungal burden as measured by
qRT-PCR, the general tendency of increasing and
decreasing fungal burden as well as the impact of the
inflammatory response seems well reflected by biolumi-
nescence imaging.
Impact of immunosuppression regimens on the
inflammatory response
In order to correlate survival curves, weight loss, fungal
burden from DNA quantification and bioluminescence
with histopathological findings, additional experiments
were performed, in which mice were sacrificed one day
(early) and three days (late) post infection. For the clo-
drolip condition, mice were sacrificed eight days after
infection to assess any later effect of treatment on mice
survival. Lungs were removed, and thin sections were
studied for the evaluation of the recruitment of immune
effector cell lineages and fungal tissue invasion.
Clodrolip treatment
Lung instillation with clodrolip was expected to reduce
the number of AM, which are generally denoted as the
first cellular line of host innate immune defense through
phagocytosis and killing of inhaled conidia. To confirm
the reduction in the number of AM, the BAL fluid of
non-infected mice were sampled two days after intrana-
sal administration of clodrolip or liposomes, respectively.
Flow cytometry was used to quantify the number of AM
within the BAL fluid. The clodrolip treatment resulted
in a numeric depletion of 60% of AM (8.30 × 10
4 ±1×
10
4 versus 2.03 × 10
5 ±1 . 8×1 0
4)w h e nc o m p a r e dt o
control liposome treated animals (p < 0.05). Further-
more, the viability of the residual AM subset was only
50% as evaluated by trypan blue staining. Taken
together, clodrolip treatment depleted or resulted in the
death of 80% of AM compared to control mice.
When the cell populations in BAL were evaluated one
day post-infection, we noted a 3.2-fold decrease (22 ±
11 versus 71 ± 28%) in the concentration of AM and a
2.6-fold increase (77.5 ± 10 versus 29 ± 28%) in the
neutrophil concentration in clodrolip-treated mice com-
pared to control liposome-treated mice (Figure 3A).
Thus, AM depletion did not result in an apparent defect
but rather in airway neutrophil recruitment 24 h post-
infection.
Furthermore, we performed an evaluation of the lumi-
nescence in the BAL one day after infection, comparing
clodrolip versus liposomes (control) or cortisone acetate
treated mice. Cortisone acetate was used as a positive
control for fungal germination within the lung tissue,
because we previously showed that cortisone acetate
inhibits the killing capacity of AM and resulted in the
germination of conidia even one day after infection
[20,21]. Mice treated with clodrolip had a fourfold lower
BAL luminescence signal than cortisone actetate-treated
mice (102000 ± 37000 versus 394000 ± 19500 photons
flux) (Figure 3B), consistent with the finding that pre-
served airway neutrophil recruitment under these condi-
tions can inhibit the conidial germination. However,
although not significantly different, the signal in the
BAL from clodrolip treated mice was higher than that
of liposome treated control mice (102000 ± 37000 ver-
sus 66300 ± 19500). Nevertheless, germination and
mycelium formation was inhibited in AM-depleted mice
as confirmed by lung histopathology analyses performed
one and eight days post infection (see below).
Neutrophils may act as the first line of defense against
conidia
One day post-infection, the lungs of clodrolip-treated
mice contained multifocal lesions (Figure 4A) charac-
terised by scattered hemorrhagic foci associated with
small (surface < 200 μm
2) perivascular, peribronchiolar,
or intra-bronchiolar/alveolar inflammatory infiltrates
(Figure 4B). At this stage, few macrophages were
detected, which implies that alveolar macrophage deple-
tion was not compensated by massive monocyte
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Page 5 of 22recruitment at day one after infection. The cellular infil-
trates contained mostly karyorrhectic (i.e. fragmented)
neutrophils (Figure 4C, E), embedded in a necrotic
material associated with extravasated erythrocytes. Clus-
ters of non-germinated conidia were observed in the
neutrophilic infiltrates (Figure 4D, F).
Eight days post-infection, the lungs of euthanized mice
displayed inflammatory lesions (Figure 5A) characterised
by multifocal hemorrhages and peri-vascular/bronchiolar
lymphocyte and plasma cell infiltration (Figure 5B, C).
Very few non-germinated conidia were detected in the
cytoplasm of macrophages located in alveolar spaces
(Figure 5D, E). At this stage,m o r p h o m e t r i ca n a l y s i s
revealed that the total surface of the inflammatory cell
infiltrates was 2.9 ± 1.7% of the total lung parenchymal
surface on the histologic sections, in comparison to 1.8 ±
1.0% at day one after infection (Table 1). These data indi-
cate that, at early post-infection time points, neutrophils
have supplanted AM as a first line of host defense, leading
to the destruction and inactivation of conidia prior to ger-
mination and hyphae formation. The observed absence of
fungal hyphae under these conditions correlated with the
inability to detect an increase of the bioluminescence
signal.
Cortisone acetate treatment versus the combination of
cortisone acetate and clodrolip
As shown in Figure 1C, 2 (inlet) and 6, mice treated
with cortisone acetate (Figure 6A-B) or the combination
of cortisone acetate and clodrolip (Figure 6C-D) dis-
played the highest peak of lung luminescence between
day one and day two post infection. Both treatment
groups experienced 100% mortality five to six days after
infection. In addition to the thoracic region, a significant
luminescence was observed from the abdomen of all
infected mice. However, the abdominal signal declined
rapidly and therefore was unlikely to result from fungal
dissemination. This was confirmed in histology, by the
absence of fungal CFU from the liver, spleen, stomach,
and kidneys (data not shown). Therefore, it is likely that
some conidia were swallowed and maintained for some
time within the intestinal tract without manifestation of
an infection. In contrast, a luminescence signal from the
sinus regions has been observed in 20% of infected
mice. This signal steadily increased and peaked during
the terminal survival phase of illness (Figure 6E). In par-
allel with the bioluminescence increase from the sinus
region, these infected mice became ataxic and displayed
a disturbance in equilibrium. These data demonstrate
that bioluminescence imaging can detect signals from
extrathoracic sites.
Neutrophils encircle A. fumigatus conidia and limit their
infiltrative potential, but fail to prevent their germination
under corticosteroid-treatment
For histopathological analysis, five mice were sacrificed
one day post-infection to visualise fungal outgrowth and
the immune response in the early phase of infection.
The late phase of infection, at which all the five studied
mice displayed strong clinical signs of illness, was stu-
died in lung sections derived from dying animals 3-4
days post-infection. Lung histopathology at one day
after infection revealed multifocal inflammatory lesions
mostly centred on alveoli but also involving some bron-
chial/bronchiolar spaces (Figure 7A). They were charac-
terised by small to large infiltrates (surface up to 500 μm
2)
of neutrophils that were often karyorrhectic and associated
with the necrosis of the overlying epithelium (Figure 7C,
E). The total surface of inflammatory infiltrates was 3.8 ±
2.0% of the total lung parenchyma surface (Table 1).
Figure 3 Neutrophil recruitment inhibits the conidial
germination in alveolar macrophages-depleted mice one day
after infection. (A): Alveolar macrophage and neutrophil
populations were counted in BAL fluids one day after infection of
mice treated with the liposome control and clodrolip. N = 5 mice
per group. One of three independent experiments is shown.
* denotes a p-value < 0.05. (B): Light emission in BAL-fluids one day
after infection of mice treated with liposome control (upper cell
well), clodrolip (middle cell well) and cortisone acetate (lower cell
well). BAL cells were collected by cytospin centrifugation using
labtek chamber slides. D-luciferin was incorporated to the medium
and luminescence acquired after 10 min with the IVIS 100 system.
The graph shows the total luminescence evaluated by using the
living image software 3.1.
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Page 6 of 22Figure 4 At the early stage of pulmonary colonisation, neutrophil influx limits fungal germination after clodrolip treatment.( A ) :
Multifocal inflammatory lesion centred on bronchi/bronchioles and blood vessels (arrowheads). (B): Inflammatory cells observed in alveolar
spaces (arrowheads). (C, E): Inflammatory infiltrates containing fragmented neutrophils (suppuration, white stars). (D, F): In the inflammatory
infiltrates (black star) only non-germinated conidia (arrowheads) were observed. A, B, C, E: HE staining; D, F: GMS staining.
Figure 5 Eight days post-inoculation, hyphal growth was not observed in clodrolip treated mice. (A): At low magnification, very few
lesions (hemorrhages and small inflammatory infiltrates) were observed (arrowheads). (B, C): Inflammatory infiltrates were characterised by
perivascular and peribronchiolar accumulation of lymphocytes and plasma cells. (D, E): A small number of non-germinated conidia, located in
the cytoplasm of alveolar macrophages were observed. A, B, C: HE staining; D, E: GMS staining.
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in bronchiolar and alveolar spaces, as well as in the interal-
veolar septae (Figure 7B), but they displayed different
maturation stages. Bronchiolar spaces contained mature
septated hyphae (Figure 7D), in contrast to alveolar spaces,
where only early germinating conidia and short hyphal
germlings were detected (Figure 7F). These experiments
confirm the data obtained from the quantification of fun-
gal DNA within the infected tissues, which implied that
conidia are rapidly germinating under cortisone acetate
treatment.
In comparison to clodrolip-treated mice (Table 1),
cortisone acetate-treated mice exhibited a higher and
more severe level of pulmonary parenchyma destruction,
and conidia and hyphae were at a more advanced stage
of maturation.
Three days after infection (Figure 8), pulmonary
inflammatory lesions within the corticosteroid-treated
group were multifocal, centred on bronchi/bronchioles
but secondarily extending to alveoli and blood vessels
(veins and arteries), and displayed a concentric organisa-
tion (Figure 8A). In the centre of the inflammatory
lesions, bronchiolar, alveolar and vascular spaces were
infiltrated mostly by karyorrhectic neutrophils (Figure
8C, E). Neutrophils were circled by a peripheral rim of
activated macrophages (epithelioid cells): pyogranuloma-
tous lesion (Figure 8D). This was the only condition
where pyogranulomatous lesions were observed and all
t h ef i v em i c eo ft h es t u d i e dg r o u pd i s p l a y e ds i m i l a r
lesions (nature and severity). The surface of these pyo-
granulomatous lesions was up to 1,370 μm
2;t h eg e n e r a l
inflammatory lesion filled 11.2 ± 1.9% of the total par-
enchyma surface (Table 1), indicating ongoing tissue
destruction under cortisone acetate treatment. Numer-
ous septated hyphae were detected in bronchial/bronch-
iolar spaces, but also infiltrating bronchiolar walls and
spreading to peripheral alveoli (Figure 8B, F). Although
histopathology indicates an increase in fungal biomass
at the late stage of infection, a significant proportion of
fungal cells might have been killed by neutrophil attack.
This assumption is supported by the determination of
the fungal burden by quantitative real-time PCR (Figure
2). Although this investigation was only performed on
two animals for each time point and immunosuppres-
sion regimen, this analysis indicated that the number of
living fungal cells does not seem to increase, since the
amount of fungal DNA remains rather constant when
compared to the early time point. Additionally, the mas-
sively observed tissue destruction indeed might cause
hypoxic conditions accompanied by a decrease of light
emission from lung tissues of corticosteroid treated
mice.
The same pattern of severe lesions was observed after
the clodrolip/cortisone acetate treatment (data not
Table 1 Comparison between the lesion profiles in the different immunosuppressive conditions.
Lesions Recruted Inflammatory Cells Fungi
Proportion of inflammatory
infiltrate surface
Major
Localisation
Necrosis Neutrophiles Macrophages Conidia Hyphae
Chlodrolip Early
1 day PI
1.8 ± 1.0% Random
distribution
- ++ +/- ++ -
Late
8 days PI
2.9 ± 1.7% Perivascular
Peribronchiolar
-- + + -
Cortisone Acetate
Early
1 day PI
3.8 ± 2.0% Alveoli ++ ++ +/- ++ +/-
Late
3 days PI
11.2 ± 1.9% Bronchi
Bronchioles
+++ +++ ++ ++ +++
RB6-8C5
Early
1 day PI
1.9 ± 0.5% Random
distribution
+/- - +/- + -
Late
3 days PI
18.9 ± 2.8% Bronchi
Bronchioles
+++ - +++ ++ +++
Cyclophosphamide
Early
1 day PI
No infiltrate Bronchioles +/- +/- - +/- -
Late
3 days PI
No infiltrate All structures ++++ - - + ++++
A group of five mice was studied at each time point, for each condition. The lesions were very similar between the different animals in a same group (PI: post-
infection). A group of three mice was studied for the measurement of the surface of inflammatory cell infiltrates in tissue sections (morphometric analysis, 22 to
40 microscopic fields covering an entire lung section for each animal).
- none, +/- minimal, + mild, ++ moderate, +++ marked, ++++ severe.
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Page 8 of 22Figure 6 Bioluminescence enables detection of thoracic and extra thoracic signals in cortisone acetate treated mice. (A): Time response
study of luminescence emission from mice immunosuppressed either with cortisone acetate (A, B) or with a combination of cortisone acetate
and clodrolip (C-E). Mice were intranasally infected with 2 × 10
6 conidia. A cohort of 10 mice received liposomes as a control prior to infection
(F). Images of day one (D1) and two (D2) post-infection are shown. Luminescence was monitored 10 min after intraperitoneal injection of
D-luciferin. Images from ventral (V) and dorsal (D) views of the sinus region, six days after infection (D6) of mice treated with both, cortisone
acetate and clodrolip, are shown (E). The graph in (G) represents the average of the total photon flux measured from a defined thoracic region
from each individual animal of the respective cohort. (H): Time course of total luminescence from chest, abdomen and head regions from
animals receiving the combination of cortisone acetate and clodrolip.
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Page 9 of 22shown). Therefore, depletion of alveolar macrophages
does not exhibit additional effects on the development
of invasive aspergillosis in the presence of cortisone
acetate.
Histopathological analysis from the sinus regions per-
formed at the late stage revealed an inflammatory lesion
(multifocal to coalescing suppurative sinusitis) with a
very high density of intralesional fungal hyphae (Figure
9). No histological lesions were observed in the brain
(not shown). Whether the disturbance in equilibrium
may be caused by fungal infection of the inner ear can-
not be excluded, but had not been investigated here.
However, contrasting the decline in bioluminescence in
infected lung tissues under cortisone acetate treatment,
the steadily increasing bioluminescence from the sinus
region might indeed resemble an increase of the fungal
biomass.
Collectively, these results suggest that in the cortisone
acetate condition, the early infiltration of neutrophils
results in parenchymal destruction without stopping
conidial germination. Three days post infection, neutro-
phils encircling A. fumigatus conidia and hyphae may
limit fungal spread. However, despite the obvious killing
of some fungal cells, these neutrophils are not able to
completely prevent disease progression and mice suffer
strongly from the severe inflammatory processes.
RB6-8C5 treatment
To determine the effect of neutrophil depletion at speci-
fic time points in relation to infection, mice were treated
Figure 7 The cortisone acetate mediated neutrophil infiltration did not prevent conidia germination even one day after infection. (A):
Multifocal inflammatory lesion extending from bronchi/bronchioles to alveoli (arrowheads). (B): Numerous fungal cells can be detected in the
inflammatory infiltrates (arrowheads). (C, E): In the bronchioles (C) as well as in the alveoli (E), inflammatory infiltrates contained numerous
neutrophils, which were very often fragmented (suppuration). (D, F): Bronchiolar spaces contained mature hyphae (D) in contrast to alveolar
spaces that contained poorly mature hyphae and early germinating conidia (F). A, C, E: HE staining; B, D, F: GMS staining.
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antibody RB6-8C5 (anti-Gr-1; anti-Ly6G/Ly6C). This
method of transient neutrophil depletion was chosen
because it is well characterized and specific compared
with other methods (eg, administration of cyclophospha-
mide [17] or irradiation and results in more than 99%
depletion in the circulation [22]. Treatment of mice
with the anti-neutrophil antibody RB6-8C5 led to a high
susceptibility of mice for IA (Figure 1B). However, the
luminescence signal was significantly lower than that
obtained for cortisone acetate treated mice and the
highest values were obtained two days post infection,
later than the day 1 peak observed in the cortisone acet-
ate-treated group (Figure 1C).
Monocytes and macrophages are insufficient to prevent
conidial germination and hyphal spread in the absence of
neutrophils
One day post infection in neutrophil-depleted mice (Fig-
ure 10), multifocal pulmonary lesions were observed,
characterised by small infiltrates (surface less than
150 μm
2) of mononucleated cells (mainly macrophages
but also lymphocytes and rare plasma cells), located
either in alveolar spaces or in interalveolar interstitial
tissue (Figure 10A, C). Neutrophils were not observed
within these lesions, indicating a successful depletion of
this cell population by the RB6-8C5 treatment. Lesions
represented 1.9 ± 0.5% of the parenchymal surface
(Table 1). Germinating conidia and short hyphae were
Figure 8 Despite strong infiltration of neutrophils under cortisone acetate treatment, growth of the fungus in bronchiolar and
alveolar spaces is not prevented in the late stage of infection. (A): Multifocal to coalescing inflammatory lesion centred on bronchioles
(black stars) and extending to alveoli and blood vessels. (B): Mycelium growing mainly in the bronchiolar spaces (black stars), but also extending
to alveoli (arrowheads). (C): Lesions displayed a concentric organisation: in the centre, neutrophils accumulated and infiltrated bronchioles
(arrowhead) and blood vessel walls (arrow). (D): Neutrophils (black star) were circled by a peripheral rim of activated macrophages (Δ). (E, F):
Fungi displayed a high infiltrative potential, extending from bronchiolar spaces to alveoli. A, C, D, E: HE staining; B, F: GMS staining.
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cally surrounded by small clusters of inflammatory infil-
trates (Figure 10D, F), or within the cytoplasm of AM
(Figure 10E). In contrast to the cortisone acetate trea-
ted-mice, no difference in the fungal maturation stage
was observed between intra-bronchiolar and intra-alveo-
lar fungi, and fungi displayed less parenchyma infiltra-
tion potential.
T h el a t es t a g e( t h r e ed a y sp o s ti n f e c t i o n )o fI A
induced by transient neutrophil depletion (Figure 11)
was characterised by a multifocal inflammatory lesion,
centered on bronchi and bronchioles but extending to
alveoli and blood vessels as well (Figure 11A). The
lesions were extensive, with large areas of necrosis and
vascular involvement that was more pronounced than in
cortisone acetate-treated mice (Table 1). Mature sep-
tated fungal hyphae were observed infiltrating bronchio-
lar and alveolar spaces as well as interstitial tissue
(Figure 11B, D). Hyphae were more numerous than in
cortisone acetate-treated mice and infiltrated the pul-
monary parenchyma more readily (Figure 11A, B). The
inflammatory infiltrate was predominately composed of
mononuclear cells (monocytes/macrophages and lym-
phocytes and plasma cells) (Figure 10C). Individual
l e s i o n sm e a s u r e du pt o5 0 0μm
2 in area and accounted
18.9 ± 2.8% of the total lung section surface (Table 1),
which is even higher than the area affected under corti-
sone acetate treatment.
Taken together, these data indicate that the recruit-
ment of mononuclear cells, in the absence of neutro-
phils, is insufficient to prevent conidial germination,
hyphal outgrowth and tissue infiltration. It is likely that
the severe vascular and parenchymal lesions observed in
RB6-8C5-treated mice prevented the development of
high bioluminescent signals in vivo. This is most likely
due to hypoxia resulting from the pulmonary parench-
yma destruction, which was even more severe than
under cortisone acetate treatment.
Cyclophosphamide treatment
Treatment with cyclophosphamide was expected to
cause severe neutropenia accompanied by a reduction of
monocytes. However, resident alveolar macrophages
were not expected to be affected by this treatment. Bio-
luminescence imaging revealed that cyclophosphamide
treatment resulted in a delayed (apparent at day 2 to
day 3 post-infection), but steadily increasing biolumines-
cence signal until mice succumbed to progressive dis-
ease (Figure 1C and Figure 2 inlet).
At the late stage of infection, in the absence of
inflammatory cells, A. fumigatus disseminates rapidly in
cyclophosphamide-treated mice
At day one post-infection (Figure 12), histopathology
revealed no significant histological lesion but rare neu-
trophils could be observed in bronchiolar spaces (Figure
12A, C). Non-germinating and rare early-germinating
conidia were detected throughout bronchiolar and
alveolar spaces (Figure 12B, D). As in the cortisone acet-
ate-treated mice, intrabronchiolar fungi (Figure 12F)
were seen at a more advanced stage of maturation than
intra-alveolar fungal cells (Figure 12E). However, hyphal
branching was rarely observed at the early stage, even in
intrabronchiolar regions (Table 1), confirming the data
from the quantitative analysis of the fungal DNA from
infected lungs, which implied, despite the small animal
group studied, that conidia germination is delayed under
Figure 9 After intranasal inoculation, mice treated by cortisone acetate could develop a suppurative sinusitis.( A ) :T h en a s a ls i n u s
cavities were filled by a suppurative exudate containing fragmented neutrophils (black stars). (B): A high number of intralesional mature hyphae
were detected in the exudate as well as along the nasal sinus epithelium (inlay, Δ).
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treatment (Figure 2).
In contrast, the late stage of pulmonary infection (Fig-
ure 13) was characterised by a severe and diffuse
destruction of bronchoalveolar structures (Figure 13A),
without any inflammatory cell infiltrate (Table 1). The
parenchyma destruction was due to severe fungal par-
enchymal and vascular wall infiltration, leading to
thrombosis and infarcts (Figure 13B). Bronchial, bronch-
iolar, and alveolar epithelial cells were necrotic (Figure
13C). Grocott methenamine silver staining showed a
high number of mature septated fungal hyphae, spread-
ing diffusely from bronchiolar spaces to alveoli and infil-
trating blood vessels (Figure 13D), as already assumed
from the increasing bioluminescent signal and the high
amount of fungal DNA obtained from these tissues (Fig-
ure 2). Collectively these results demonstrate that
immune effector cells recruitment is vital to limit hyphal
growth and dissemination.
Discussion
In this study we successfully imaged murine invasive
pulmonary aspergillosis using bioluminescence record-
ings in a serial manner. We applied different immuno-
suppression regimens to elucidate their impact on the
susceptibility of mice to invasive aspergillosis (IA). By
combining bioluminescence imaging and histopathology
we gained new insights on the impact of different
Figure 10 In the early stage after RB6-8C5 treatment, although immunocompetent, macrophages were not sufficient to avoid conidial
germination. (A): Multifocal small inflammatory infiltrates randomly scattered in the pulmonary parenchyma. (B): Small clusters of fungi were
observed in the inflammatory infiltrates. (C): Inflammatory infiltrates were located in alveolar spaces or interalveolar interstitial tissue. They
contained mononucleated cells (mainly macrophages but also rare lymphocytes and plasma cells). (D, E, F): Early germinating conidia were
observed in the inflammatory infiltrates either free or in the cytoplasm of alveolar macrophages (arrowheads). Note that the conidia and hyphae
were less mature than under cortisone acetate treatment (Figure. 6). A, C: HE staining; B, D, E, F: GMS staining.
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phils) in host defense against conidial germination and
tissue invasion.
Interestingly, under conditions of high inflammation,
such as the cortisone acetate or RB6-8C5 treatment,
bioluminescence signal intensities nicely reflected the
early germination of conidia, but only showed limited
correlation with the amount of alive fungal cells at later
time points of infection. Quantification of the fungal
DNA from late time points of cortisone acetate treated
animal implied that the number of living cells stayed
constant over time. This result confirmed that neutro-
phils, although affected in their killing capacity by the
corticosteroid, limited the uncontrolled spreading of
fungal mycelium through the lung tissues. However, one
would have expected that the bioluminescence signal
stays at a high level rather than declining. Due to the
large necrotic areas (covering approximately 11% of
the whole lung parenchyma), we attribute the decline of
the bioluminescence signal to the development of
hypoxia, as observed in tissues after stroke or myocardial
infarction and for growing tumors, which become
hypoxic when they outgrow the vascular supply [23]. The
limitation of bioluminescence imaging in hypoxic tissues
has already been described by investigating the decrease
in bioluminescence of luciferase-transfected gliosarcoma
tumor cells under defined hypoxic in vitro conditions
[24]. Additionally, bioluminescent implanted tumor cells
can become necrotic at a certain age with subsequent
decline of bioluminescence although the tumor itself
Figure 11 In the late stage after RB6-8C5 treatment, macrophages and recruited monocytes were unable to prevent fungal lung
colonisation. (A): Multifocal large inflammatory infiltrates centred on bronchioles but extending to alveoli and blood vessels (arrowheads). (B):
Fungi displayed a high infiltrative potential with a marked extension to alveoli (arrowheads). (C): Inflammatory infiltrates were composed of
mononucleated cells; mainly macrophages (inlay). (D): Hyphae were mature and displayed a high invasive potential. A, C: HE staining; B, D: GMS
staining.
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to be comparable to our results obtained during biolumi-
nescence imaging of invasive aspergillosis under corti-
sone acetate and RB6-8C5 antibody treatment. In
addition, the occurrence of hypoxia has been assumed
from the attenuated virulence of A. fumigatus mutants
with a defective adaptation to hypoxic conditions [26]
and seems confirmed independently by our biolumines-
cence measurements. Although the correlation of the
bioluminescent signal at later time points with the fungal
burden is limited the decline in bioluminescence under
in vivo conditions in late stages of infection acts as an
indicator of tissue destruction and hypoxia and indicates
the imminent death of the animals.
Despite the low correlation of fungal biomass and bio-
luminescence at late time points after infection in the
cortisone acetate and RB6-8C5 treatments, a good cor-
relation between the increase in the fungal biomass and
the bioluminescence was observed under the cyclopho-
sphamide regimen. Under this treatment, although the
growing hyphae were responsible for diffuse parenchyma
lesions, the accessibility of oxygen remains possible in
the absence of inflammation. At late time points, an
ongoing increase of the luminescence signal reflects the
increase of biomass. Therefore, cyclophosphamide
immunosuppression seems best suited to follow the
effect of antifungal drug treatment on clearance of fun-
gal infections.
Figure 12 In the early stage, A. fumigatus germination was delayed after cyclophosphamide treatment. (A): At a low magnification, no
significant histological lesion was observed. B: Only small clusters of conidia were multifocally detected (arrowheads). C. At a high magnification,
only small infiltrates of neutrophils were noted in bronchiolar and alveolar spaces. (D): Non-germinated and early germinating conidia were
observed in these inflammatory infiltrates. (E): Intra-alveolar conidia at a very early stage of germination (swollen conidia). Some conidia were
observed in the cytoplasm of alveolar macrophages (arrowhead). (F): Intra-bronchiolar conidia were either swollen or started to form hyphae.
Note that this stage of maturation is much less pronounced than observed in the early stage of cortisone acetate (Figure 6D) and RB6-8C5
treatment (Figure 9D). A, C: HE staining; B, D, E, F: GMS staining.
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concerning the impact of different immune effector cells
in the defense against invasive aspergillosis. Alveolar
macrophages (AM) were assumed to play an important
role in clearance of conidia from tissues and provide a
“first-line of defense” against A. fumigatus infections [3].
AM are thought to trigger the recruitment of immune
effector cells to the site of infection after recognition
and phagocytosis of conidia [27] through the release of
inflammatory and chemotactic mediators.
Due to the importance of AM in conidial host defense,
we expected that their reduction by the clodrolip treat-
ment would increase the susceptibility of mice to IA.
This assumption was not confirmed experimentally.
Intranasally clodrolip-treated mice showed a 80% reduc-
tion in the number and viability of AM [28,29], but a 2.6
fold increase in the number of BAL fluid neutrophils, one
day post-infection. A significant increase in the neutro-
phil number in BAL fluid of macrophage-depleted (clo-
drolip-treated) mice 24 hours after instillation of
Pseudomonas aeruginosa has already been reported.
However, in this work macrophage-deficient mice
showed impaired bacterial clearance [30]. In contrast, in
our model, neutrophil migration into the airways of
macrophage-depleted infected mice is likely to have pre-
vented conidial germination per se.
Supporting this idea, we found that the thoracic
region or BAL fluid of AM-depleted animals only
Figure 13 In the late stage after cyclophosphamide treatment no inflammatory response was observed and A. fumigatus rapidly
colonised the pulmonary parenchyma. (A): Diffuse lesion characterised by a total absence of inflammatory response with a severe destruction
of the bronchoalveolar structures (black star: bronchiole; white star: pulmonary artery). (B): Severe parenchyma colonisation by the fungus with
infiltration of bronchioles (black star) as well as pulmonary arteries (white star). (C): Destruction of the bronchiolar (black star), alveolar, and
vascular (white star) walls by hyphae. (D): Branched mature hyphae were observed, displaying a high infiltrative potential. A, C: HE staining; B, D:
GMS staining.
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trol levels (Figure 3). This finding correlated with survi-
val data and histopathological findings, demonstrating
an absence of conidial germination in AM-depleted
mice. These results do not fully exclude the possibility
that (i) there were still sufficient residual viable alveolar
macrophages to trigger an immune response due to
only 80% of depletion and (ii) the possibility of recruit-
ment of peripheral monocytes or (iii) that the increase
in recruited neutrophils was able to control the infection
in the absence of normal alveolar macrophage counts.
The first and second scenarios, however, appear rather
unlikely, because hardly any macrophages or monocytes
were observed in histopathologic analyses at day one
after infection. The third scenario appears quite likely,
because histopathological analysis revealed a strong infil-
tration of neutrophils encasing ungerminated conidia. In
contrast, functionally attenuated neutrophils and macro-
phages in corticosteroid-treated mice allowed develop-
ment of invasive disease despite robust cellular
recruitment in the lung parenchyma.
The treatment of mice with cortisone acetate or the
combination of clodrolip and cortisone acetate led to
100% mortality and invasive fungal growth within the
lung tissue. Although systemic administration of corti-
costeroids increases the number of circulating neutro-
phils by three- to fivefold [31], their ability to damage
A. fumigatus hyphae is strongly reduced [32]. One day
post-infection, the lung tissue showed an extensive neu-
trophilic infiltration that surrounded germinating coni-
dia. These neutrophils were able to delay uncontrolled
tissue invasion by killing some proportion of fungal
hyphae. As a consequence of the neutrophil infiltration
severe tissue damage accompanied by parenchymal
destruction (necrosis) was observed, leading to a
decreased bioluminescence as described above. It is also
noteworthy that under cortisone acetate treatment the
efficiency of alveolar macrophages in inhibiting conidial
germination after phagocytosis was strongly defective.
None of the other treatment groups yielded hyphal
germlings as early as one day post-infection. It could be
assumed that this rapid germination is due to growth
stimulation via A. fumigatus corticosteroid receptors
[33]. However, experiments, in which different concen-
trations of cortisone acetate were added to A. fumigatus
cultures, neither stimulated conidia germination, nor
increased the light emission (data not shown). Since cor-
tisone acetate itself constitutes an “inactive” corticoster-
oid derivative, which is converted into “active” cortisol
during metabolism in the liver [34], it might be possible
that a stimulation of germination is only mediated by
this metabolite rather than by cortisone acetate.
Another possibility for the rapid germination of coni-
dia is given by a neutrophil mediated tissue destruction
releasing large amounts of nutrients from tissue cells,
which enhanced the germination speed under this
immunosuppresive regimen. The mild inflammation
under RB6-8C5 treatment one day post infection and
the absence of inflammation under cyclophosphamide
treatment may not provide the same nutritional condi-
tions leading to a delayed germination when compared
to the cortisone acetate treatment.
Another piece of evidence that supports the depen-
dence on the number and functional integrity of neutro-
phils in the clearance of A. fumigatus is the observation
that RB6-8C5 treatment renders mice highly susceptible
to IA. Our results confirm earlier studies [17,35,36,22]
and clearly demonstrate that AM and monocytes cannot
functionally compensate for loss of neutrophils. RB6-8C5
treated mice succumbed to IA with a similar time course
as cortisone acetate-treated mice. However, a notable dif-
ference between both models was the absence of neutro-
phils and the severe tissue infiltration by mononuclear
cells (mainly macrophages) seen in RB6-8C5-treated
mice at days three to four after infection. This tissue infil-
tration covered approximately 19% of the total lung sur-
face and was more severe than observed in the cortisone
acetate treatment group (approximately 11%).
Treatment with cyclophosphamide was assumed to
have the strongest impact on the development of IA. It
results in: (i) a reduction in the number of monocytes
and neutrophils in the peripheral blood by 64 and 88%,
respectively [37-39], (ii) a reduction in the number of
AM and neutrophils in an experimental lung infection
with Streptococcus pneumoniae [40], (iii) an impairment
of phagocytosis [41], (iv) an immune dysfunction
through reactive oxygen intermediate-induced damage
to the immune system cells [42-44] without alteration of
the degranulation process [38] and finally (v) a failure in
neutrophil chemotactic function [45]. As expected,
under this treatment, we did not observe inflammation
within the infected tissues. Therefore, mice treated with
cyclophosphamide succumb to uncontrolled infection
resulting in tissue destruction and blood vessel infiltra-
tion by the fungal mycelium and the fungal biomass
produced under this regimen was by far most pro-
nounced at late time points (Figure 2 and 13). In con-
trast, cortisone acetate and RB6-8C5 treatment likely
results in additional tissue injury due to the strong, but
ineffective host inflammatory response.
Interestingly, the luminescence additionally enabled us
to detect and monitor extrathoracic growth of A. fumi-
gatus in particular in the sinus area even in cortisone
acetate treated mice. The resulting suppurative sinusitis
may indicate a defect in the innate immune response in
the upper respiratory airway rather than dissemination.
Reflecting on the outcome of aspergillosis from the
different infection models, we conclude that AM are
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response to recruit other immune effector cells. How-
ever, although able to slow fungal outgrowth, AM are
insufficient to clear the infection in the absence of neu-
trophils. Neutrophil depletion by the RB6-8C5 antibody
leads to a predominately monocyte infiltration to the
site of infection. Influx of mononuclear cells is insuffi-
cient to replace neutrophil function. Corticosteroid
treatment leads to the most rapid germination of coni-
dia, which may reflect functional inactivation of alveolar
macrophages followed by the ongoing influx of neutro-
phils, which are attenuated in their conidial and hyphal
killing mechanisms. Although after corticosteroid-treat-
ment, neutrophils were not able to inactivate growing
hyphae completely, they retarded hyphal tissue invasion
at the great cost of massive tissue inflammation and
necrosis. Therefore, preservation of neutrophil number
and function is indispensable for the control and clear-
ance of A. fumigatus infections. Macrophages may play
an important role in orchestrating the immune
response, but their action alone is not sufficient to com-
bat A. fumigatus.
Our data suggest that the early neutrophil recruitment
is crucial to form an efficient immune response against
A. fumigatus. This assumption is supported by two pre-
vious studies, which have reported that mice deficient in
the chemokine receptor CXCR2 (CXCR2-/- mice) display
a defect in neutrophil recruitment and were more sus-
ceptible to IA [36,35]. Therefore, we conducted a preli-
minary investigation, in which we used a bioluminescent
A. fumigatus strain to monitor the pathogenesis of
CXCR2-/- mice. This experiment revealed an overall
average of 3-fold increase of bioluminescence signal
within the thoracic region of knockout compared to wild
type mice. At day 6 post infection, a 12 fold-increase in
luminescence was observed in knockout animals with a
m o r t a l i t yr a t eo fm o r et h a n6 0 % ,w h e r e a sa l li m m u n e
competent wild-type mice survived (data not shown).
Although this experiment has to be confirmed by charac-
terizing the histological lesions, it fits well with the
assumption that the early recruitment of immunocompe-
tent neutrophils is one of the most important factors to
combat the initial onset of invasive aspergillosis.
Conclusions
Taken together, the bioluminescent A. fumigatus strain
provides a valuable tool to define the progressive nature
of IA under different immunosuppressive regimens,
although the quantification of fungal biomass by biolu-
minescent imaging was difficult to assess especially
under inflammatory conditions. However, in order to
confirm that the tendency of the progression of infec-
tion is correctly assigned by bioluminescence imaging,
we confirmed our results by histopathologic analysis and
quantification of the fungal DNA by qRT-PCR. The lat-
ter method is the most reliable measure for quantifica-
tion of living fungal cells, but cannot be used in time
response analyses since the animals need to be sacrificed
to gain the infected organs. Although larger animal
groups and all immunosuppression regimens need to be
investigated by quantitative real-time PCR, it appears
that bioluminescence imaging cannot be used for repla-
cing alternative methods for quantification if an exact
value for fungal biomass in a certain animal and time
point needs to be determined. This is mainly due to the
fact that bioluminescence does not increase or decrease
linearly with the burden as determined by quantitative
real-time PCR since determination of light emission
from living animals is strongly dependent on availability
of oxygen. However, and most importantly, biolumines-
cence imaging was indeed able reflecting the general
tendency of the speed of fungal germination, tissue inva-
sion and inflammatory response. Histopathology
revealed a rapid germination of conidia under cortisone
acetate treatment and, coinciding, a high bioluminescent
signal was obtained. At later stages, neutrophils partially
inactivated fungal mycelium and caused tissue necrosis
under corticosteroid treatment. In agreement, the biolu-
minescent signal strongly declined. Contrarily, under
cyclophosphamide treatment conidia germination is
delayed. Therefore, one day after infection only a weak
bioluminescence signal was detected. However, at later
time points under this regimen, a strong fungal invasion
of the lung parenchyma was observed in histopathology
and confirmed by quantification of fungal DNA. Coin-
ciding, the bioluminescence strongly increased. There-
fore, bioluminescence signals cannot be used for
comparison of the fungal burden among different
immunosuppression regimens but within one well-
defined regimen, the bioluminescence correlates well
with the independently determined fungal germination
s p e e d ,i m m u n er e s p o n s ea n dt h ef a t eo ff u n g a lc e l l s
within the infected tissue.
By using the bioluminsescence imaging system, we
found that experiments that perturb the number,
recruitment, and function of neutrophils result in pre-
dictable patterns of invasive aspergillosis that can be
imaged serially in real time with bioluminescence ima-
ging. In vivo monitoring shows light emission from
lungs as soon as 24 hours post infection, indicating
rapid outgrowth of the fungus. Therefore, early diagno-
sis of fungal infections is of tremendous importance. In
addition, our study provides new insights into the innate
immune response emphasizing an essential role for neu-
trophils as recruited phagocytes in the early innate
response to A. fumigatus.
The currently constructed strain seems most suitable
for disease monitoring in host system that have
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m e n t ) .T h er e p r o d u c i b l ei maging results from small
groups of animals and is likely to help in substantial
cost savings in trials that examine the effects of pharma-
ceutical compounds, antibodies, and genetic or cellular
lesions in small animal models of IA. In further studies,
bioluminescence imaging will be used to assess the effi-
cacy of antifungal drugs under in vivo conditions. A
successful monitoring of clearance of fungal infections
might help improving future treatment strategies for
combating invasive fungal infections.
Methods
Strain culturing and mouse infection
A. fumigatus strain C3
The bioluminescent A. fumigatus strain C3 [16] was
used in all experiments and was subcultured on 2% malt
extract agar slants for 8 days at room temperature. Con-
idia were harvested by scrapping them from the slant
culture with 2 ml of phosphateb u f f e r e ds a l i n es u p p l e -
mented with 0.1% Tween 20 (PBST). The suspension
was filtered through a 40 μm cell strainer (BD Falcon,
Bedford MA, USA) to separate conidia from contami-
nating mycelium.
Mice
Male BALB/cJ mice (25 g, 8 week-old) were supplied by
the Centre d’ Elevage R. Janvier (Le Genest Saint-Isle,
France). Mice were fed with normal mouse chow and
water ad libitum and were reared and housed under
standard conditions with air filtration. Mice were cared
for in accordance with Institut Pasteur guidelines in
compliance with the European animal welfare regula-
tion. Prior to intranasal infection one of the following
immunosuppression regimens was applied:
(i) Cortisone acetate treatment
Cortisone acetate was suspended in sterile phosphate
buffered saline (PBS) to give a final concentration of
125 mg/ml. The suspension was sonicated at 37°C for
at least 30 min to prepare a homogenous suspension.
Immunosuppression was performed as described pre-
viously [46], whereby mice were immunosuppressed
with two single doses of 25 mg cortisone acetate (Sigma
Aldrich, St Louis, MO), which were injected intraperito-
neally three days before and immediately prior to infec-
tion with conidia (day 0).
(ii) RB6 purification and treatment
The RB6-8C5 anti-neutrophil antibody was purified
from ascites (gift from Robert Coffman, DNAX Corp.)
by chromatography over a HiTrap protein G column (1
ml bed volume, GE Healthcare, Freiburg, Germany). Ali-
quots containing 500 μg of purified antibody in PBS
were shock-frozen in liquid nitrogen and stored at -80°C
until use. For depletion of neutrophils, each mouse
received 100 μg of RB6-8C5 antibody (150 μl) injected
intraperitoneally one day prior to infection.
(iii) Cyclophosphamide treatment
For bone marrow stem cell depletion, cyclophosphamide
was injected intraperitoneally (200 mg/kg) four and one
day prior to infection. The cyclophosphamide injection
was repeated every other day post-infection.
(iv) Clodrolip treatment
Clodronate liposomes (Clodrolip) were prepared as
described previously [47,48]. Clodronate was a gift of
Farchemia, Treviglio, Italy. The liposomes act as carriers
for clodronate, which is toxic for phagocytic cells. Two
days prior infection, a volume of 83 μlc o n t a i n i n g
1.5 mg of Clodrolip was directly instilled into the nares of
anesthetized mice to deplete alveolar macrophages. Mice
instilled with empty liposomes were used as controls.
Additionally, certain mice received both clodrolip and
cortisone acetate. This regimen included one dose of
cortisone acetate and clodrolip at day -3, clodrolip alone
a td a y- 2a n dc o r t i s o n ea c e t a t ea l o n ea tt h ed a yo f
infection.
Mouse infection
Mice were anesthetised by an intramuscular injection of
0.1 ml of a solution containing 10 mg ketamine (Imal-
gène 1000, Merial, Lyon, France) and 0.8 mg xylazine
(Bayer, Leverkusen, Germany) per mouse. 2 × 10
6 coni-
dia in 25 μl of PBS 0.1% Tween 20 were applied to the
nares of the mice. Deep anaesthesia ensured inhalation
of the conidial inoculum. Infected mice were daily mon-
itored by bioluminescence imaging using an IVIS 100
system (Xenogen Corporation, Alameda, CA, USA).
Weight loss was monitored at 24 h intervals starting
f r o md a y- 4 .I na l le x p e r i m e n t s ,m i c ew e r ek e p tf o ra
maximum of 15 days post infection.
Bronchoalveolar lavages
Bronchoalveolar lavage (BAL) fluid was harvested as
previously described [20]. Mice were euthanized by
injection of Pentobarbital (Sanofi Santé Animale,
Libourne, France) and the respiratory tract was exposed
by dissection. A small incision was made near the top of
the trachea, and a blunt-end 20-gauge needle was
inserted and tied in place with surgical thread around
the trachea. BAL fluid was obtained by 10 rounds of fill-
ing the lungs with 0.7 ml PBS and withdrawing as much
of the liquid as possible. The samples were centrifuged
to collect BAL fluid cells. BAL fluid cells were washed
and resuspended in 1 ml PBS and aliquots were
removed for counting with a hemocytometer and for
cytospin centrifugation on a microscope slide, followed
by DNA staining with Hoechst 33342 for identification
of cell types. To determine the numbers of macrophages
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microscopy fields were identified.
Flow cytometry using macrophage marker antibodies
F4/80 (Miltenyi-Biotec, Bergisch Gladbach, Germany)
and Gr-1 (Biolegend, San diego CA USA) was used to
verify the extent of macrophage depletion within the
BAL of clodrolip treated animals. Cell viability was eval-
uated using the trypan dye exclusion (Sigma-Aldrich).
In vivo and in vitro imaging of bioluminescence
Images were acquired using an IVIS 100 system accord-
ing to the manufacturer’si n s t r u c t i o n sa n da sp r e v i o u s l y
described [16]. In brief, 100 μl of PBS containing 3.33
mg D-luciferin was intraperitoneally injected in mice
before each measurement. Mice were anesthetized using
ac o n s t a n tf l o wo f2 . 5 %i s o f l u o r a n em i x e dw i t ho x y g e n
using an XGI-8 gas anesthesia system (Xenogen Cor-
poration). Images from mice were acquired 10 min after
luciferin injection. Acquisition and quantification were
performed using Living Image software version 3.1
(Xenogen Corporation). Quantification of photons per
second emitted by each organ was performed by defin-
ing regions of interest corresponding to the respective
organ of interest. The presence of A. fumigatus within
the different organs was confirmed by histopathological
analysis.
For in vitro measurement of fungal germination within
the BAL, D-luciferin in a final concentration of 10 mM
was added directly to cells pelleted at the surface of
chamber slides. The reaction was pre-incubated for 10
min at room temperature and measurement was per-
formed with the IVIS 100 system.
Determination of fungal DNA from infected lungs by
quantitative real-time PCR
A quantitative real-time PCR approach was selected to
determine the fungal burden by quantification of the
amount of fungal DNA among the total DNA isolated
from lung tissues. The lung of a mouse not infected
with A. fumigatus served as negative control. Four mice
either immunosuppressed with cortisone acetate or with
cyclophosphamide were infected intranasally with 2 ×
10
6 conidia of the bioluminescent strain C3. From each
group two were sacrificed on day 1 after infection (early
time point) and two mice at day 3 (late time point). The
control mouse was sacrificed on day three. Biolumines-
cence at the early time point was measured from alive
animals, whereas at the late time point bioluminescence
was additionally recorded from explanted lungs by direct
injection of D-luciferin. Lungs were cut into small pieces
and briefly washed in phosphate buffered saline. Excess
liquid was removed on paper tissues and the weight of
lungs was determined. The complete lung from each
animal was frozen in liquid nitrogen and ground to a
fine powder. Approximately 100 mg of each powdered
lung was used for DNA extraction via the MasterPure
yeast DNA extraction kit (Epicentre Biotechnologies,
Biozym Scientific GmbH, Hessisch Oldendorf, Germany)
as described in the manufacturer’s protocol. As a slight
modification and for obtaining DNA of higher purity
grade, an ethanol precipitation step of the DNA was
included. The amount of DNA extracted from the lung
tissues was quantified by a NanoDrop spectrophot-
ometer. All samples were diluted to 100 ng/μla n d
quantified again to confirm the DNA concentration of
each sample. As a standard for quantification of the
amount of fungal DNA among the total DNA extracted
from lung tissues, A. fumigatus genomic DNA was iso-
lated by the same procedure from a culture grown for
20 h on minimal medium containing glucose (50 mM)
and peptone (0.5% w/v) as nutrient sources. The Taq-
Man quantitative real-time PCR approach used based on
the standard operation procedure (SOP) described else-
where http://www.sacmm.org/pdf/Determination%20of%
20Tissue%20Fungal%20Burden%20utilizing%20Quantita-
tive%20Real%20Time%20PCR.pdf. The TaqMan® Univer-
sal PCR Master Mix (Applied Biosystems, Darmstadt,
Germany) was used in all approaches. In brief, the geno-
mic DNA region coding for the 18S rRNA from
A. fumigatus was used as the target for amplification
and quantification of fungal DNA. A specific probe con-
taining a 6-FAM-phosphoramidit labeling at the 5’-end
and a TAMRA labeling at the 3’-end was used for detec-
tion of the amplification products. Amplification was
performed on a StepOnePlus Real-Time PCR system
(Applied Biosystems) and data were evaluated by using
the StepOne software version 2.0 (Applied Biosystems).
The standard curve on genomic DNA from A. fumigatus
was generated from three technical replicates, whereby
each replicate contained 6 dilutions in the range
between 100 and 3.125 ng per reaction (stability index
of standard curve = 0.99). The amplification program
consisted of an initial denaturation at 95°C for 10 min
followed by 40 cycles with denaturation for 15 s at 95°C,
annealing for 30 s at 54°C, and amplification for 30 s at
72°C. All DNA samples from lung tissues were mea-
sured from 3 dilutions (from 500 to 125 ng total DNA
per reaction) in two technical replicates. All six data
points from each sample were used for calculation of
the amount of fungal DNA per μg of total DNA.
Histopathology
For the histopathological analysis, a group of five mice
was studied at each time point (early and late time
point), for each immunosuppressive condition. After
necropsy, organs of interest (lung, nasal sinus, and
brain) were immediately fixed in 4% neutral-buffered
formalin and embedded in paraffin. Mouse skull and
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solution of 4% buffered formalin and 10% trichloroacetic
acid for approximately 2 months. Five μm sections were
cut and stained with hematoxylin and eosin (HE) and
Grocott’s methenamine silver (GMS, for detection of
fungi) [49]. The lesion profiles were very similar
between mice of the same group.
T h ep r e s e n c eo fc o n i d i aa n dh y p h a ew e r eq u a n t i f i e d
as evaluated in general in histology within tissue thin
sections. This semiquantitative fungal burden is pre-
sented as follow: - none, +/- minimal, + mild, ++ mod-
erate, +++ marked, ++++ severe.
The total surface of inflammatory cell infiltrates in tis-
sue sections was measured by morphometric analysis in
22 to 40 microscopic fields, covering an entire lung sec-
tion for each animal, at 4× magnification. Three mice
were analyzed for each immunosuppressive condition.
ImageJ 1.38× software (National Institute of Health,
USA) was used for this analysis. Reliability was assessed
by 20 repeated measurements over several days (coeffi-
cient of variation: 1.6%).
Statistical analysis
All experiments were performed at least in triplicate
with groups of 5 mice for each treatment. Comparisons
between multiple groups were performed using one-way
ANOVA. Significance between groups was determined
with the Fisher’s Least Significant Difference post hoc
test. A p value of < 0.05 was considered statistically sig-
nificant. Data are reported in the figures as means ±
standard deviation.
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